Novavax Inc.

NASDAQ: NVAX · Real-Time Price · USD
9.58
0.15 (1.59%)
At close: Aug 15, 2025, 3:59 PM
9.63
0.52%
After-hours: Aug 15, 2025, 07:58 PM EDT

Novavax Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.08B 1.25B 682.16M 885.19M 822.75M 831.69M 818.78M 815.27M 1.53B 1.29B 1.91B 1.85B 1.29B 1.4B 1.15B 1.2B 1.18B 919.45M
Cost of Revenue
125.63M 147.44M 182.14M 294.35M 332.66M 352.39M 337.67M 370.56M 706.22M 921.52M 902.64M 724.55M 289.95M 18.88M 3.67M n/a n/a n/a
Gross Profit
953.09M 1.11B 500.02M 590.85M 490.09M 479.3M 481.12M 444.71M 821.56M 367.76M 1.01B 1.12B 1B 1.38B 1.14B 1.2B 1.18B 919.45M
Operating Income
356.08M 411.41M -242.83M -295.32M -286.93M -392.47M -566.51M -626.82M -628.38M -1.17B -644.74M -1.23B -1.41B -1.27B -1.69B -1.04B -931.26M -602.45M
Interest Income
n/a n/a n/a n/a 2.86M 5.98M 10.3M 14.9M 16.21M 13.09M 8.77M 4.17M n/a n/a n/a n/a n/a n/a
Pretax Income
431.39M 488.52M -176.62M -279.74M -288.88M -395.6M -543.03M -550.84M -585.51M -1.15B -653.65M -1.3B -1.45B -1.29B -1.71B -1.06B -943.35M -612.1M
Net Income
422.82M 478.7M -187.5M -284.86M -294.33M -398.71M -545.06M -548.92M -586.76M -1.16B -657.94M -1.32B -1.48B -1.32B -1.74B -1.08B -949.91M -615.11M
Selling & General & Admin
237.79M 298.48M 332.69M 409.58M 446.29M 438.71M 468.95M 475.37M 490.79M 505.23M 488.69M 411.24M 366.16M 331.16M 298.36M 275.46M 254.54M 199.1M
Research & Development
358.01M 387.33M 391.07M 451.49M 470.55M 583.08M 737.5M 830.65M 1.03B 1.1B 1.24B 1.94B 2.04B 2.33B 2.53B 1.97B 1.86B 1.32B
Other Expenses
-1.1M n/a -8.8M -14.9M -17.88M -17.88M -96.46M -159.93M -156.95M -156.95M -67.92M 1.78M -2.61M 50K -1.6M -1.74M 3.61M 952K
Operating Expenses
601.5M 690.4M 737.15M 875.97M 766.82M 871.77M 960.25M 984.15M 1.36B 1.45B 1.65B 2.35B 2.41B 2.66B 2.83B 2.25B 2.11B 1.52B
Interest Expense
11.62M 10.24M 20.07M 16.61M 15.23M 14.21M 14.42M 14.9M 16.21M 19.32M 19.52M 20.06M 21.07M 20.81M 21.13M 20.94M 19.86M 16.94M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a -165.37M -165.37M -165.37M -165.37M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
722.63M 842.43M 923.87M 1.18B 1.11B 1.22B 1.3B 1.35B 2.07B 2.37B 2.56B 3.07B 2.7B 2.67B 2.83B 2.25B 2.11B 1.52B
Income Tax Expense
8.56M 9.82M 10.88M 5.12M 5.46M 3.11M 2.03M -1.92M 1.25M 2.81M 4.29M 23.16M 26.73M 28.86M 29.21M 12.61M 6.57M 3.02M
Shares Outstanding (Basic)
162.02M 161.05M 160.24M 160.05M 148.38M 139.92M 123.68M 103.43M 89.36M 86.16M 79.82M 78.27M 78.14M 79.38M 75.67M 74.75M 74.12M 73.02M
Shares Outstanding (Diluted)
177.22M 177.63M 160.24M 160.05M 165.85M 139.92M 123.68M 103.43M 104.06M 86.16M 79.82M 78.27M 78.14M 80.71M 75.67M 74.75M 74.12M 73.03M
EPS (Basic)
2.61 3.06 -1.21 -2.14 -2.64 -3.1 -5.46 -6.3 -7.19 -14.37 -8.4 -17.3 -19.46 -17.68 -23.29 -14.81 -13.71 -9.26
EPS (Diluted)
2.26 2.65 -1.33 -2.26 -2.76 -3.17 -5.53 -6.37 -7.26 -14.37 -8.44 -17.34 -19.5 -17.72 -23.29 -14.81 -13.71 -9.26
EBITDA
495.57M 554.89M -108.04M -216.35M -228.25M -337.06M -487.39M -497.69M -534.02M -1.1B -604.11M -1.25B -1.41B -1.25B -1.68B -1.03B -916.49M -589.24M
EBIT
454.45M 510.21M -156.54M -263.13M -273.65M -381.39M -528.62M -535.94M -569.3M -1.13B -633.77M -1.28B -1.43B -1.27B -1.69B -1.04B -923.49M -595.16M
Depreciation & Amortization
41.12M 44.69M 48.5M 46.77M 45.39M 44.33M 41.23M 38.25M 35.28M 31.93M 29.65M 25.5M 21.42M 17.11M 12.66M 10.78M 7.71M 6.28M